Ahead Of WWDC, Apple Analyst Foresees AI Integration Boosting Stock Value by $30-$40 Per Share: ‘New AI Era For Cupertino Begins’
Apple shares have underperformed its Magnificent 7 peers, as the company largely stayed away from the AI party.
Arcturus’ Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
ASML Remains Top Pick In EU Semicaps, Analyst Highlights Key Role In AI Infrastructure And Multiple Expansion
BofA Securities analyst reiterated Buy rating on ASML Holding N.V. with a raised price target, reflecting higher confidence in demand for EUV tools and higher gross margin. ASML remains top pick in EU Semicaps due to its irreplicable role in AI infrastructure buildout.
Lyft Competing In Lock-step With Uber Technologies: Analysts Eye ‘Multiple Shots’ On Goal For Growth
Lyft's FY27 targets reveal anticipated growth, prompting mixed analyst reactions, with upgrades, downgrades, and price forecast adjustments.
Nio’s Units Ramp But Margins Remain Pressured: Analysts Provide Q1 Takeaways
Nio's Q1 results showed a 7% YOY decline in revenues and 201% growth in gross profits. Analysts remain neutral, as the company's margins continue to be under pressure even as deliveries and revenues ramp.
Ciena Sees ‘Early Signs Of A Recovery,’ 3 Analysts Dive Into Q2 Results
Ciena shows early signs of recovery and positive analyst takeaways. Yet, its share price declined and analysts lowered their forecasts.
DocuSign Reports A ‘Skinny Beat’ With ‘Street’s Calibration To The New Cadence May Take A Quarter Or Two’
DocuSign reported upbeat Q1 results, but the beat was less than in previous quarters. Management issued tempered expectations for near-term growth. Analysts have mixed opinions.
Dollar Tree’s Strategic Review Of Family Dollar Overdue, Analysts Cut Price Forecast
Dollar Tree's strategic review of Family Dollar is overdue, prompting analysts to cut price forecasts amid mixed Q1 results.
Lululemon Poised For Global And Men’s Market Expansion, Analysts Adjust Forecasts Following Strong Q1 Results
Lululemon Athletica beat first-quarter expectations, leading to positive analyst reactions. BofA Securities raised the price target to $440, highlighting strong sales growth and robust international performance. Wedbush noted potential for domestic improvement through innovation. J.P. Morgan emphasized LULU's international growth and e-commerce expansion. Telsey Advisory Group acknowledged improved inventory and innovation as key to overcoming domestic challenges.
Stay on Sidelines – ChargePoint Analysts Say Despite Positive Q1, Await More Proof of Growth
Analysts are positive on ChargePoint's turnaround, with solid Q1 results and expectations for improved revenue and profitability in H2 2025.